Science For The Real World: Canadian Hematology Today

Catalytic Health
  • 0,0 (0)
  • Medizin

Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Canadian Hematology Today presents robust clinical perspectives and practical insights on the treatment and management of hematologic diseases. Hosted on Acast. See acast.com/privacy for more information.

Folgen

  1. 29. Apr.

    Understanding the mechanism of BTK inhibitors

    Hosted on Acast. See acast.com/privacy for more information.

  2. 13. Jan.

    Strategic Sequencing in Relapsed Refractory Multiple Myeloma

    Hosted on Acast. See acast.com/privacy for more information.

  3. 18.11.2025

    Prise en charge des patients atteints de LLC doublement exposée et réfractaire.

    Hosted on Acast. See acast.com/privacy for more information.

  4. 18.11.2025

    Addressing the management of patients with double exposed and refractory CLL

    Sponsored by Eli Lilly Hosted on Acast. See acast.com/privacy for more information.

  5. 24.09.2025

    CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection

    Sponsored by Bristol Myers Squibb. Hosted on Acast. See acast.com/privacy for more information.

  6. 06.01.2025

    Practical considerations in the management of early rrMM in the Canadian context

    This podcast features Dr. Christopher Venner and his colleagues from the hematology community, Dr. Sylvia McCulloch, Dr. Arleigh McCurdy, and Dr. Chai Phua discussing the approach to the management of early rrMM in the Canadian context. This episode of Science for the Real World is part of Canadian Hematology Today, an open-access scientific journal for the hematology community. Hosted on Acast. See acast.com/privacy for more information.

  7. 26.06.2024

    The role of selinexor in early rrMM and sequencing in 2024.

    In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing. Hosted on Acast. See acast.com/privacy for more information.

    The role of selinexor in early rrMM and sequencing in 2024.
  • 7 Folgen

Info

Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Canadian Hematology Today presents robust clinical perspectives and practical insights on the treatment and management of hematologic diseases. Hosted on Acast. See acast.com/privacy for more information.

Informationen